An exploration of first-time dads’ sharenting with social media marketers: implications for children’s online privacy
Journal of Marketing Theory and Practice · 03.04.2023 · 31 (2) · 185-196
DOI: 10.1080/10696679.2021.2024441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Marketing Theory and Practice, online erschienen am 24.01.2022. Verfasst von Alexa K. Fox und 2 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This paper explores first-time dads’ (FTDs) decisions to engage in sharenting, or posting information about one’s child on social media, as marketers seek to connect with new parents via engagement tactics that prompt sharenting. We report survey results for 75 FTDs and eight semi-structured interviews from a separate FTD group. We find that FTDs are likely to perceive their own and their child’s information as sensitive yet be willing to share it with marketers when prompted. Marketers should appeal to FTDs’ role as “Involved Protector” via protecting their child’s digital footprint.
Zitieren
APA
Fox, A. K., Hoy, M. G., & Carter, A. E. (2023). An exploration of first-time dads’ sharenting with social media marketers: implications for children’s online privacy. Journal of Marketing Theory and Practice, 31(2), 185-196. https://doi.org/10.1080/10696679.2021.2024441
Vancouver
Fox AK, Hoy MG, Carter AE. An exploration of first-time dads’ sharenting with social media marketers: implications for children’s online privacy. Journal of Marketing Theory and Practice. 2023;31(2):185-196. doi:10.1080/10696679.2021.2024441
BibTeX
@article{Fox2023,
author = {Fox, Alexa K. and Hoy, Mariea Grubbs and Carter, Alexander E.},
title = {An exploration of first-time dads’ sharenting with social media marketers: implications for children’s online privacy},
journal = {Journal of Marketing Theory and Practice},
year = {2023},
volume = {31},
number = {2},
pages = {185--196},
doi = {10.1080/10696679.2021.2024441}
}
EUVIMED